Skip to main content
Erschienen in: La radiologia medica 3/2015

01.03.2015 | BREAST RADIOLOGY

Diffusion magnetic resonance imaging in breast cancer characterisation: correlations between the apparent diffusion coefficient and major prognostic factors

verfasst von: Paolo Belli, Melania Costantini, Enida Bufi, Giuseppe Giovanni Giardina, Pierluigi Rinaldi, Gianluca Franceschini, Lorenzo Bonomo

Erschienen in: La radiologia medica | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study was done to investigate the correlation between the apparent diffusion coefficient (ADC) and prognostic factors of breast cancer.

Materials and methods

From January 2008 to June 2011, all consecutive patients with breast cancer who underwent breast magnetic resonance imaging (MRI) and subsequent surgery in our hospital were enrolled in our study. The MRI protocol included a diffusion-weighted imaging sequence with b values of 0 and 1,000 s/mm2. For each target lesion in the breast, the ADC value was compared with regard to major prognostic factors: histology, tumour grade, tumour size, lymph node status, and age.

Results

A total of 289 patients with a mean age of 53.49 years were included in the study. The mean ADC value of malignant lesions was 1.02 × 10−3 mm2/s. In situ carcinomas, grade 1 lesions, and tumours without lymph nodal involvement had mean ADC values that were significantly higher than those of invasive carcinomas (p = 0.009), grade 2/3 lesions (p < 0.001), and tumours with nodal metastases (p = 0.001). No significant differences were observed in ADC values among tumours of different sizes or among patient age groups.

Conclusions

ADC values appear to correlate with tumour grade and some major prognostic factors.
Literatur
1.
Zurück zum Zitat Raka EA, Ellis IO (2011) Modern classification of breast cancer: should we stick with morphology or convert to molecular profile characteristics. Adv Anat Pathol 18:255–267CrossRef Raka EA, Ellis IO (2011) Modern classification of breast cancer: should we stick with morphology or convert to molecular profile characteristics. Adv Anat Pathol 18:255–267CrossRef
2.
Zurück zum Zitat Rakha EA, Reis-Filho JS, Baehner F et al (2010) Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res 12:207PubMedCentralPubMed Rakha EA, Reis-Filho JS, Baehner F et al (2010) Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res 12:207PubMedCentralPubMed
3.
Zurück zum Zitat Bone B, Aspelin P, Bronge L, Veress B (1998) Contrast-enhanced MR imaging as a prognostic indicator of breast cancer. Acta Radiol 39:279–284CrossRefPubMed Bone B, Aspelin P, Bronge L, Veress B (1998) Contrast-enhanced MR imaging as a prognostic indicator of breast cancer. Acta Radiol 39:279–284CrossRefPubMed
4.
Zurück zum Zitat Jinguji J, Kajiya Y, Kamimura K et al (2006) Rim enhancement of breast cancers on contrast-enhanced MR imaging: relationship with prognostic factors. Breast Cancer 13:64–73CrossRefPubMed Jinguji J, Kajiya Y, Kamimura K et al (2006) Rim enhancement of breast cancers on contrast-enhanced MR imaging: relationship with prognostic factors. Breast Cancer 13:64–73CrossRefPubMed
5.
Zurück zum Zitat Mussurakis S, Buckley DL, Horsman A (1997) Dynamic MR imaging of invasive breast cancer: correlation with tumour grade and other histological factors. Br J Radiol 70:446–451CrossRefPubMed Mussurakis S, Buckley DL, Horsman A (1997) Dynamic MR imaging of invasive breast cancer: correlation with tumour grade and other histological factors. Br J Radiol 70:446–451CrossRefPubMed
6.
Zurück zum Zitat Szabo BK, Aspelin P, Kristoffersen Wiberg M et al (2003) Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol 13:2425–2435CrossRefPubMed Szabo BK, Aspelin P, Kristoffersen Wiberg M et al (2003) Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol 13:2425–2435CrossRefPubMed
7.
Zurück zum Zitat Partridge SC, DeMartini WB, Kurland BF et al (2009) Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR 193:1716–1722CrossRefPubMed Partridge SC, DeMartini WB, Kurland BF et al (2009) Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR 193:1716–1722CrossRefPubMed
8.
Zurück zum Zitat Peters NHGM, Vincken KL, Van Den Bosch MAAJ et al (2010) Quantitative diffusion-weighted imaging for differentiation of benign and malignant breast lesions: the influence of the choice of b-values. J Magn Reson Imaging 31:1100–1105CrossRefPubMed Peters NHGM, Vincken KL, Van Den Bosch MAAJ et al (2010) Quantitative diffusion-weighted imaging for differentiation of benign and malignant breast lesions: the influence of the choice of b-values. J Magn Reson Imaging 31:1100–1105CrossRefPubMed
9.
Zurück zum Zitat Rahbar H, Partridge SC, Eby PR et al (2011) Characterization of ductal carcinoma in situ on diffusion weighted breast MRI. Eur Radiol 21:2011–2019CrossRefPubMed Rahbar H, Partridge SC, Eby PR et al (2011) Characterization of ductal carcinoma in situ on diffusion weighted breast MRI. Eur Radiol 21:2011–2019CrossRefPubMed
10.
Zurück zum Zitat Kim SH, Cha ES, Kim HS et al (2009) Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors. J Magn Reson Imaging 30:615–620CrossRefPubMed Kim SH, Cha ES, Kim HS et al (2009) Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors. J Magn Reson Imaging 30:615–620CrossRefPubMed
11.
Zurück zum Zitat Costantini M, Belli P, Rinaldi P et al (2010) Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumor aggressiveness. Clin Radiol 65:1005–1012CrossRefPubMed Costantini M, Belli P, Rinaldi P et al (2010) Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumor aggressiveness. Clin Radiol 65:1005–1012CrossRefPubMed
12.
Zurück zum Zitat Martincich L, Deantoni V, Bertotto I et al (2012) Correlations between diffusion-weighted imaging and breast cancer biomarkers. Eur Radiol 22:1519–1528CrossRefPubMed Martincich L, Deantoni V, Bertotto I et al (2012) Correlations between diffusion-weighted imaging and breast cancer biomarkers. Eur Radiol 22:1519–1528CrossRefPubMed
13.
Zurück zum Zitat Choi SY, Chang YW, Park HJ et al (2012) Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer. Br J Radiol 85:474–479CrossRef Choi SY, Chang YW, Park HJ et al (2012) Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer. Br J Radiol 85:474–479CrossRef
14.
Zurück zum Zitat Choi BB, Kim SH, Kang BJ et al (2012) Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma. World J Surg Oncol 10:126CrossRefPubMedCentralPubMed Choi BB, Kim SH, Kang BJ et al (2012) Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma. World J Surg Oncol 10:126CrossRefPubMedCentralPubMed
15.
Zurück zum Zitat Nakajo M, Kajiya Y, Kaneko T et al (2010) FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion. Eur J Nucl Med Mol Imaging 37:2011–2020CrossRefPubMed Nakajo M, Kajiya Y, Kaneko T et al (2010) FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion. Eur J Nucl Med Mol Imaging 37:2011–2020CrossRefPubMed
16.
Zurück zum Zitat Razek AA, Gaballa G, Denewer A, Nada N (2010) Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors. NMR Biomed 23:619–623CrossRefPubMed Razek AA, Gaballa G, Denewer A, Nada N (2010) Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors. NMR Biomed 23:619–623CrossRefPubMed
17.
Zurück zum Zitat Colagrande S, Carbone SF, Carusi LM et al (2006) Magnetic resonance diffusion-weighted imaging: extraneurological applications. Radiol Med 111:392–419CrossRefPubMed Colagrande S, Carbone SF, Carusi LM et al (2006) Magnetic resonance diffusion-weighted imaging: extraneurological applications. Radiol Med 111:392–419CrossRefPubMed
18.
Zurück zum Zitat Kuroki Y, Nasu K (2008) Advances in breast MRI: diffusion-weighted imaging of the breast. Breast Cancer 15:212–217CrossRefPubMed Kuroki Y, Nasu K (2008) Advances in breast MRI: diffusion-weighted imaging of the breast. Breast Cancer 15:212–217CrossRefPubMed
19.
Zurück zum Zitat Kul S, Cansu A, Alhan E et al (2011) Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. AJR 196:210–217CrossRefPubMed Kul S, Cansu A, Alhan E et al (2011) Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. AJR 196:210–217CrossRefPubMed
20.
Zurück zum Zitat Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403–410CrossRefPubMed Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403–410CrossRefPubMed
21.
Zurück zum Zitat McGuire WL (1991) Breast cancer prognostic factors: evaluation guidelines. J Natl Cancer Inst 83:154–155CrossRefPubMed McGuire WL (1991) Breast cancer prognostic factors: evaluation guidelines. J Natl Cancer Inst 83:154–155CrossRefPubMed
22.
Zurück zum Zitat Rakha EM, El-Sayed ME, Lee AHS et al (2008) Prognostic significance of Nottingham Histologic Grade in invasive breast carcinoma. J Clin Oncol 26:3153–3158CrossRefPubMed Rakha EM, El-Sayed ME, Lee AHS et al (2008) Prognostic significance of Nottingham Histologic Grade in invasive breast carcinoma. J Clin Oncol 26:3153–3158CrossRefPubMed
23.
Zurück zum Zitat Adedayo A, Onitilo MD, Engel JM et al (2009) Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res 7:4–13CrossRef Adedayo A, Onitilo MD, Engel JM et al (2009) Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res 7:4–13CrossRef
24.
Zurück zum Zitat Cianfrocca M, Gradishar W (2009) New molecular classifications of breast cancer. CA Cancer J Clin 59:303–313CrossRefPubMed Cianfrocca M, Gradishar W (2009) New molecular classifications of breast cancer. CA Cancer J Clin 59:303–313CrossRefPubMed
25.
Zurück zum Zitat Desmedt C, Haibe-Kains B, Wirapati P et al (2008) Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res 14:123–127CrossRef Desmedt C, Haibe-Kains B, Wirapati P et al (2008) Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res 14:123–127CrossRef
26.
Zurück zum Zitat Fernandes RCM, Bevilacqua JLB, Soares IC et al (2009) Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas. Histopathology 55:346–352CrossRefPubMed Fernandes RCM, Bevilacqua JLB, Soares IC et al (2009) Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas. Histopathology 55:346–352CrossRefPubMed
27.
Zurück zum Zitat Habibi G, Leung S, Law JH et al (2008) Redefining prognostic factors for breast cancer: yB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes. Breast Cancer Res 10:R86CrossRefPubMedCentralPubMed Habibi G, Leung S, Law JH et al (2008) Redefining prognostic factors for breast cancer: yB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes. Breast Cancer Res 10:R86CrossRefPubMedCentralPubMed
28.
Zurück zum Zitat Weigelt B, Horlings HM, Kreike B et al (2008) Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 21:141–150CrossRef Weigelt B, Horlings HM, Kreike B et al (2008) Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 21:141–150CrossRef
29.
Zurück zum Zitat Belli P, Costantini M, Ierardi C et al (2011) Diffusion-weighted imaging in evaluating the response to neoadjuvant breast cancer treatment. Breast J 17:610–619CrossRefPubMed Belli P, Costantini M, Ierardi C et al (2011) Diffusion-weighted imaging in evaluating the response to neoadjuvant breast cancer treatment. Breast J 17:610–619CrossRefPubMed
30.
Zurück zum Zitat National Research Ethics Service (2008) Approval for medical devices research: guidance for researchers, manufacturers, research ethics, committees and NHRR&D offices (Version 2). National Patients Safety Agency, London National Research Ethics Service (2008) Approval for medical devices research: guidance for researchers, manufacturers, research ethics, committees and NHRR&D offices (Version 2). National Patients Safety Agency, London
31.
Zurück zum Zitat Cheng L, Bai Y, Zhang J et al (2013) Optimization of apparent diffusion coefficient measured by diffusion-weighted MRI for diagnosis of breast lesions presenting as mass and non-mass-like enhancement. Tumor Biol 34:1537–1545CrossRef Cheng L, Bai Y, Zhang J et al (2013) Optimization of apparent diffusion coefficient measured by diffusion-weighted MRI for diagnosis of breast lesions presenting as mass and non-mass-like enhancement. Tumor Biol 34:1537–1545CrossRef
32.
Zurück zum Zitat Parsian S, Rahbar H, Allison KH et al (2012) Nonmalignant breast lesions: aDCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging. Radiology 265:696–706CrossRefPubMedCentralPubMed Parsian S, Rahbar H, Allison KH et al (2012) Nonmalignant breast lesions: aDCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging. Radiology 265:696–706CrossRefPubMedCentralPubMed
33.
Zurück zum Zitat Tavassoli FA, Devilee P (2003) World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Breast and Female Genital Organs. IARC Press, Lyon Tavassoli FA, Devilee P (2003) World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Breast and Female Genital Organs. IARC Press, Lyon
34.
Zurück zum Zitat Elston CW (2005) Classification and grading of invasive breast carcinoma. Verh Dtsch Ges Pathol 89:35–44PubMed Elston CW (2005) Classification and grading of invasive breast carcinoma. Verh Dtsch Ges Pathol 89:35–44PubMed
35.
37.
Zurück zum Zitat Tabar L, Fagerberg G, Day NE et al (1992) Breast cancer treatment and natural history: new insights from results of screening. Lancet 339:412–414CrossRefPubMed Tabar L, Fagerberg G, Day NE et al (1992) Breast cancer treatment and natural history: new insights from results of screening. Lancet 339:412–414CrossRefPubMed
38.
Zurück zum Zitat Bertrand KA, Tamimi RM, Jensen MR et al (2013) Mammograohic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res 15:R104CrossRefPubMedCentralPubMed Bertrand KA, Tamimi RM, Jensen MR et al (2013) Mammograohic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res 15:R104CrossRefPubMedCentralPubMed
39.
Zurück zum Zitat Dunnwald LK, Rossing MA, Li CI (2007) Hormone receptor status, tumor characteristics, and prognosis: a prospective color of breast cancer patients. Breast Cancer Res 9:R6CrossRefPubMedCentralPubMed Dunnwald LK, Rossing MA, Li CI (2007) Hormone receptor status, tumor characteristics, and prognosis: a prospective color of breast cancer patients. Breast Cancer Res 9:R6CrossRefPubMedCentralPubMed
Metadaten
Titel
Diffusion magnetic resonance imaging in breast cancer characterisation: correlations between the apparent diffusion coefficient and major prognostic factors
verfasst von
Paolo Belli
Melania Costantini
Enida Bufi
Giuseppe Giovanni Giardina
Pierluigi Rinaldi
Gianluca Franceschini
Lorenzo Bonomo
Publikationsdatum
01.03.2015
Verlag
Springer Milan
Erschienen in
La radiologia medica / Ausgabe 3/2015
Print ISSN: 0033-8362
Elektronische ISSN: 1826-6983
DOI
https://doi.org/10.1007/s11547-014-0442-8

Weitere Artikel der Ausgabe 3/2015

La radiologia medica 3/2015 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.